Maxcyte (MXCT) Change in Receivables (2020 - 2026)
Maxcyte has reported Change in Receivables over the past 6 years, most recently at -$4.8 million for Q4 2025.
- Quarterly Change in Receivables fell 4031.97% to -$4.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.1 million through Dec 2025, up 6.36% year-over-year, with the annual reading at -$1.1 million for FY2025, 6.36% up from the prior year.
- Change in Receivables was -$4.8 million for Q4 2025 at Maxcyte, down from $2.6 million in the prior quarter.
- Over five years, Change in Receivables peaked at $4.0 million in Q4 2022 and troughed at -$4.8 million in Q4 2025.
- The 5-year median for Change in Receivables is $180000.0 (2024), against an average of -$66295.0.
- Year-over-year, Change in Receivables skyrocketed 46455.56% in 2023 and then plummeted 4031.97% in 2025.
- A 5-year view of Change in Receivables shows it stood at $918900.0 in 2021, then soared by 336.63% to $4.0 million in 2022, then crashed by 141.25% to -$1.7 million in 2023, then surged by 107.37% to $122000.0 in 2024, then plummeted by 4031.97% to -$4.8 million in 2025.
- Per Business Quant, the three most recent readings for MXCT's Change in Receivables are -$4.8 million (Q4 2025), $2.6 million (Q3 2025), and $238000.0 (Q2 2025).